252 related articles for article (PubMed ID: 1279434)
1. Crystal structure of a Src-homology 3 (SH3) domain.
Musacchio A; Noble M; Pauptit R; Wierenga R; Saraste M
Nature; 1992 Oct; 359(6398):851-5. PubMed ID: 1279434
[TBL] [Abstract][Full Text] [Related]
2. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.
Noble ME; Musacchio A; Saraste M; Courtneidge SA; Wierenga RK
EMBO J; 1993 Jul; 12(7):2617-24. PubMed ID: 7687536
[TBL] [Abstract][Full Text] [Related]
4. Role of native topology investigated by multiple unfolding simulations of four SH3 domains.
Gsponer J; Caflisch A
J Mol Biol; 2001 May; 309(1):285-98. PubMed ID: 11491296
[TBL] [Abstract][Full Text] [Related]
5. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
6. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced strain in hydrogen bonds of the c-Src SH3 domain detected by NMR.
Cordier F; Wang C; Grzesiek S; Nicholson LK
J Mol Biol; 2000 Dec; 304(4):497-505. PubMed ID: 11099375
[TBL] [Abstract][Full Text] [Related]
8. Structure of the pleckstrin homology domain from beta-spectrin.
Macias MJ; Musacchio A; Ponstingl H; Nilges M; Saraste M; Oschkinat H
Nature; 1994 Jun; 369(6482):675-7. PubMed ID: 8208297
[TBL] [Abstract][Full Text] [Related]
9. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
10. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
Qiu X; Pohl E; Holmes RK; Hol WG
Biochemistry; 1996 Sep; 35(38):12292-302. PubMed ID: 8823163
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the tyrosine kinase c-Src.
Xu W; Harrison SC; Eck MJ
Nature; 1997 Feb; 385(6617):595-602. PubMed ID: 9024657
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
13. Prediction and structural characterization of an independently folding substructure in the src SH3 domain.
Yi Q; Bystroff C; Rajagopal P; Klevit RE; Baker D
J Mol Biol; 1998; 283(1):293-300. PubMed ID: 9761691
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation.
Martín-García JM; Luque I; Mateo PL; Ruiz-Sanz J; Cámara-Artigas A
FEBS Lett; 2007 May; 581(9):1701-6. PubMed ID: 17418139
[TBL] [Abstract][Full Text] [Related]
15. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of the PX domain, a target of the SH3 domain.
Hiroaki H; Ago T; Ito T; Sumimoto H; Kohda D
Nat Struct Biol; 2001 Jun; 8(6):526-30. PubMed ID: 11373621
[TBL] [Abstract][Full Text] [Related]
19. The role of backbone motions in ligand binding to the c-Src SH3 domain.
Wang C; Pawley NH; Nicholson LK
J Mol Biol; 2001 Nov; 313(4):873-87. PubMed ID: 11697910
[TBL] [Abstract][Full Text] [Related]
20. An SH2-SH3 domain hybrid.
Russell RB; Barton GJ
Nature; 1993 Aug; 364(6440):765. PubMed ID: 7689175
[No Abstract] [Full Text] [Related]
[Next] [New Search]